Search Within

Shanu Modi

  1. "Andrea Barrio"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Biostatistics Service (4)
  2. Breast Medicine Service (4)
  3. Department of Medicine (4)
  4. Department of Pathology and Laboratory Medicine (4)
  5. Epidemiology and Biostatistics (4)
  6. Population Sciences Research Program (4)

More Groups

People
  1. Andrea Barrio (4)
  2. Andrew Seidman (4)
  3. Chau Dang (4)
  4. Edi Brogi (4)
  5. Emanuela Ferraro (4)
  6. Hannah Wen (4)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (1)
Publications
  1. npj Breast Cancer (2)
  2. Annals of Oncology (1)
  3. Journal of Clinical Oncology (1)
Publishers
  1. Nature Publishing Group (2)
  2. American Society of Clinical Oncology (1)
  3. Oxford University Press (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Chew, S. M.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D.; Modi, S.; Seidman, A. D.; Wen, H.; Brogi, E.; Robson, M.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Prognostic implications of HER2 gain in patients with HR+/ HER2-breast cancer (BC) and TNBC after neoadjuvant chemotherapy (NAC)
    Meeting Abstract

    Ferraro, E.; Chew Minmin, S.; Nemirovsky, D.; Chen, Y.; Barrio, A. V.; Modi, S.; Seidman, A.; Wen, H.; Brogi, E.; Robson, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Invasive disease free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Meeting Abstract

    Chew, S.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D. W.; Modi, S.; Seidman, A. D.; Wen, H. Y.; Brogi, E.; Robson, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Ferraro, E.; Singh, J.; Patil, S.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Barrio, A. V.; Malani, R.; Mellinghoff, I. K.; Boire, A.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save